Valuation: CTT Pharmaceutical Holdings, Inc.

Market Cap 4.4M 3.85M 3.55M 3.28M 6.23M 420M 6.33M 42.45M 16.67M 207M 16.53M 16.17M 711M P/E 2024
-11.9x
P/E 2025 -22.2x
Enterprise Value 4.41M 3.85M 3.56M 3.28M 6.23M 420M 6.34M 42.48M 16.68M 207M 16.55M 16.19M 712M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
50.43%
Yield 2024 *
-
Yield 2025 -
1 day-6.00%
1 week-2.08%
Current month-6.00%
1 month-2.08%
3 months+7.80%
6 months-4.08%
Current year+17.30%
1 week 0.06
Extreme 0.061
0.08
1 month 0.06
Extreme 0.061
0.08
Current year 0.05
Extreme 0.0515
0.1
1 year 0.02
Extreme 0.024
0.1
3 years 0
Extreme 0.003
0.15
5 years 0
Extreme 0.003
0.15
10 years 0
Extreme 0.003
2.17
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member 71 2014-09-08
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
12-14BuyCompany 8,300 0.0389%
11-19BuyCompany 200,000 0.9368%
11-19BuyCompany 62,900 0.2946%
Change 5-day change 1-year change 3-year change Capi.($)
-6.00%-2.08%+116.92%+487.50% 4.4M
+0.58%+3.79%+4.16%+11.62% 50.44B
-2.22%-1.64%+385.40%+586.81% 40.63B
-0.54%+0.91%+25.57%-5.28% 34.88B
-1.36%-3.48%+17.88%+55.14% 33.67B
+1.21%-0.79%+4.46%+35.18% 26.29B
-1.81%+0.94% - - 17.11B
+0.51%-4.75%+63.97%+122.60% 15.29B
-9.37%-29.97%+37.45%+39.42% 10.62B
+0.23%-0.26%+15.51%+21.54% 13.74B
Average -1.77%-1.91%+74.59%+150.50% 24.27B
Weighted average by Cap. -0.70%-0.03%+84.54%+131.31%

Financials

2024 2025
Net sales - -
Net income -250K -219K -202K -186K -354K -23.87M -360K -2.41M -947K -11.76M -940K -919K -40.42M -156K -136K -126K -116K -220K -14.87M -224K -1.5M -590K -7.33M -585K -573K -25.18M
Net Debt 16.82K 14.71K 13.57K 12.53K 23.78K 1.6M 24.18K 162K 63.67K 790K 63.15K 61.78K 2.72M 3.46K 3.02K 2.79K 2.57K 4.89K 330K 4.97K 33.31K 13.08K 162K 12.97K 12.69K 558K
Logo CTT Pharmaceutical Holdings, Inc.
CTT Pharmaceutical Holdings, Inc. specializes in drug delivery systems technology within the pharmaceutical industry. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. It rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. It offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. It is a thin film for treating dogs and cats.
Employees
1
Date Price Change Volume
26-07-10 US$0.0705 -6.00% 20,206
26-07-09 US$0.0750 +4.17% 10,140
26-07-08 US$0.0720 -5.88% 13,270
26-07-07 US$0.0765 +6.25% 8,500
26-07-06 US$0.0720 -4.00% 1,004
  1. Stock Market
  2. Stocks
  3. CTTH Stock